KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Asset Utilization Ratio (2021 - 2025)

Recursion Pharmaceuticals' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.05 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 3.93% year-over-year to 0.05; the TTM value through Dec 2025 reached 0.05, down 3.93%, while the annual FY2025 figure was 0.05, 8.7% down from the prior year.
  • Asset Utilization Ratio reached 0.05 in Q4 2025 per RXRX's latest filing, up from 0.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.09 in Q3 2024 to a low of 0.02 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.05 recorded in 2025.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 278.38% in 2022, then plummeted 62.73% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.02 in 2021, then surged by 278.38% to 0.06 in 2022, then rose by 14.34% to 0.07 in 2023, then decreased by 22.05% to 0.05 in 2024, then dropped by 3.93% to 0.05 in 2025.
  • Per Business Quant, the three most recent readings for RXRX's Asset Utilization Ratio are 0.05 (Q4 2025), 0.03 (Q3 2025), and 0.05 (Q2 2025).